Hematologic effects of cardiac disease.
D000293:Adolescent; D000743:Anemia, Hemolytic / Q000097:blood / Q000188:drug therapy; D000747:Anemia, Hypochromic / Q000209:etiology; D000755:Anemia, Sickle Cell / Q000150:complications; D001791:Blood Platelet Disorders / Q000150:complications; D001815:Bloodletting; D002648:Child; D002675:Child, Preschool; D006330:Heart Defects, Congenital / Q000097:blood; D006331:Heart Diseases / Q000097:blood* / Q000150:complications; D006350:Heart Valve Prosthesis; D006402:Hematologic Diseases / Q000209:etiology*; D006487:Hemostasis; D006801:Humans; D007501:Iron / Q000627:therapeutic use; D010949:Plasma; D010952:Plasma Substitutes / Q000627:therapeutic use; D011086:Polycythemia / Q000209:etiology / Q000628:therapy; D011183:Postoperative Complications / Q000517:prevention & control; D011300:Preoperative Care; D013771:Tetralogy of Fallot / Q000150:complications
D010952:Plasma Substitutes; D007501:Iron